Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.

ABSTRACT:

SUBMITTER: Kim S 

PROVIDER: S-EPMC9533323 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature